New Search

If you are not happy with the results below please do another search

48 search results for:

1

OneRay Key Updates Delivering Next-Generation GenAI Capabilities

/0 Comments/in
OneRay Key Updates Delivering Next-Generation GenAI Capabilities   The pace of generative AI evolution in healthcare continues to accelerate at an unprecedented rate. We're pleased to share the key updates now available in OneRay Version 3, delivering a series of transformative enhancements to our GenAI platform that reinforce our commitment to providing Pharmaceutical, Biotech, and [...]
3

Generative AI is set to transform medical affairs

/0 Comments/in
Generative AI is set to transform medical affairs' strategic approach to patient impact. Generative AI is a transformative force reshaping how we approach patient care in Pharma, Biotech, and Medtech. At FFI Ventures, we’re leading this change, empowering and accelerating Medical Affairs teams as they transition from strategy design to real-world use case implementation. We’re [...]
4

Maximizing HCP engagement: the omnichannel advantage

/0 Comments/in
Maximizing HCP engagement: the omnichannel advantage Coping with increasingly restrictive access to the audience, a vast range of different interests in products and services, and the average human attention span now reduced to a mere 8 seconds, pharmaceutical companies continue to build seamless, integrated customer experiences across preferred online and offline channels. The core objective [...]
5

Continuous Evolution and Value-Add of Our Gen AI Agents

/0 Comments/in
Continuous Evolution and Value-Add of Our Gen AI Agents Our generative AI agents, or "bots" that we co-create with and implement in Pharma, Biotech & Medtech organizations are multi-talented, able to take on a wide range of business tasks and challenges. These agents are pre-trained and validated by domain experts before releasing to teams or [...]
6

Private generative AI is rapidly delivering value for Pharma

/0 Comments/in
Private generative AI is rapidly delivering value for Pharma As companies make progress with generative AI, they are increasingly capturing and delivering value. Specific examples in 2024 include Lilly, Sanofi, Pfizer, Roche, Boehringer Ingelheim, Novo Nordisk and aiCure). Generative AI has the potential to revolutionize the pharma and biotech industry. By applying this technology to [...]
7

Build Engagement through WhatsApp Business

/0 Comments/in
Build Engagement through WhatsApp Business In today's fast-paced life, effective communication is paramount. With WhatsApp Business, we enable our Partners in the Pharma Industry to reach their audiences with relevant, targeted, and compliant messages. Furthermore, it's beyond sending messages, as we open a direct line to the audience's most personal device. Supporting related projects—from omnichannel [...]
8

Return on Invesment of AI

/0 Comments/in
Return on Investment of AI Is your organization planning to initiate or expand its AI use to achieve next year’s objectives? We're excited to announce our upcoming webinar, "Return on Investment (ROI) of AI" in collaboration with the swiss health quality association (shqa) and dedicated to colleagues in Swiss affiliates. Building on the success of [...]
9

How do companies get value out of AI in Medical Affairs?

/0 Comments/in
How do companies get value out of AI in Medical Affairs? With budget season upon most organizations, the questions about where to invest and how to deliver growth results or realize efficiencies are top of mind. Reflecting on 18 months with generative AI solutions and continued exchanges and discussions about yet more transformative potential of [...]
10

Early Diagnosis in Rare Diseases: The Power of Technology

/0 Comments/in
Early Diagnosis in Rare Diseases: The Power of Technology In the complex world of rare diseases, early diagnosis is both critical and challenging. With over 7,000 known rare diseases affecting millions worldwide, the need for innovative diagnostic approaches has never been greater. At FFI Ventures, we collaborate closely with life-science industry partners to leverage cutting-edge [...]